TY - JOUR AU - Piccini, J. P. AU - Hammill, B. G. AU - Sinner, M. F. AU - Jensen, P. N. AU - Hernandez, A. F. AU - Heckbert, S. R. PY - 2012 DA - 2012// TI - Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993–2007 JO - Circ Cardiovasc Qual Outcomes VL - 5 UR - https://doi.org/10.1161/CIRCOUTCOMES.111.962688 DO - 10.1161/CIRCOUTCOMES.111.962688 ID - Piccini2012 ER - TY - JOUR AU - Benjamin, E. J. AU - Wolf, P. A. AU - D’Agostino, R. B. AU - Silbershatz, H. AU - Kannel, W. B. AU - Levy, D. PY - 1998 DA - 1998// TI - Impact of atrial fibrillation on the risk of death: the Framingham Heart Study JO - Circulation VL - 98 UR - https://doi.org/10.1161/01.CIR.98.10.946 DO - 10.1161/01.CIR.98.10.946 ID - Benjamin1998 ER - TY - JOUR AU - Lin, H. J. AU - Wolf, P. A. AU - Kelly-Hayes, M. AU - Beiser, A. S. AU - Kase, C. S. AU - Benjamin, E. J. PY - 1996 DA - 1996// TI - Stroke severity in atrial fibrillation. The Framingham Study JO - Stroke VL - 27 UR - https://doi.org/10.1161/01.STR.27.10.1760 DO - 10.1161/01.STR.27.10.1760 ID - Lin1996 ER - TY - JOUR AU - Patel, N. J. AU - Deshmukh, A. AU - Pant, S. AU - Singh, V. AU - Patel, N. AU - Arora, S. PY - 2014 DA - 2014// TI - Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning JO - Circulation VL - 129 UR - https://doi.org/10.1161/CIRCULATIONAHA.114.008201 DO - 10.1161/CIRCULATIONAHA.114.008201 ID - Patel2014 ER - TY - JOUR AU - Wang, T. J. AU - Larson, M. G. AU - Levy, D. AU - Vasan, R. S. AU - Leip, E. P. AU - Wolf, P. A. PY - 2003 DA - 2003// TI - Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study JO - Circulation VL - 107 UR - https://doi.org/10.1161/01.CIR.0000072767.89944.6E DO - 10.1161/01.CIR.0000072767.89944.6E ID - Wang2003 ER - TY - JOUR AU - Chang, S. H. AU - Kuo, C. F. AU - Chou, I. J. AU - See, L. C. AU - Yu, K. H. AU - Luo, S. F. AU - Huang, L. H. AU - Zhang, W. AU - Doherty, M. AU - Wen, M. S. AU - Kuo, C. T. AU - Yeh, Y. H. PY - 2017 DA - 2017// TI - Association of a family history of atrial fibrillation with incidence and outcomes of atrial fibrillation: a population-based family cohort study JO - JAMA Cardiol VL - 2 UR - https://doi.org/10.1001/jamacardio.2017.1855 DO - 10.1001/jamacardio.2017.1855 ID - Chang2017 ER - TY - JOUR AU - Go, A. S. AU - Hylek, E. M. AU - Phillips, K. A. AU - Chang, Y. AU - Henault, L. E. AU - Selby, J. V. PY - 2001 DA - 2001// TI - Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.18.2370 DO - 10.1001/jama.285.18.2370 ID - Go2001 ER - TY - JOUR AU - Movahed, M. R. AU - Hashemzadeh, M. AU - Jamal, M. M. PY - 2005 DA - 2005// TI - Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease JO - Int J Cardiol VL - 105 UR - https://doi.org/10.1016/j.ijcard.2005.02.050 DO - 10.1016/j.ijcard.2005.02.050 ID - Movahed2005 ER - TY - JOUR AU - Sensi, F. AU - Potter, T. AU - Cresti, A. AU - Severi, S. AU - Breithardt, G. PY - 2015 DA - 2015// TI - Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives JO - Cardiovasc Diagn Ther VL - 5 ID - Sensi2015 ER - TY - JOUR AU - Huxley, R. R. AU - Filion, K. B. AU - Konety, S. AU - Alonso, A. PY - 2011 DA - 2011// TI - Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation JO - Am J Cardiol VL - 108 UR - https://doi.org/10.1016/j.amjcard.2011.03.004 DO - 10.1016/j.amjcard.2011.03.004 ID - Huxley2011 ER - TY - JOUR AU - Plitt, A. AU - McGuire, D. K. AU - Giugliano, R. P. PY - 2017 DA - 2017// TI - Atrial fibrillation, type 2 diabetes, and non-vitamin k antagonist oral anticoagulants: a review JO - JAMA Cardiol VL - 2 UR - https://doi.org/10.1001/jamacardio.2016.5224 DO - 10.1001/jamacardio.2016.5224 ID - Plitt2017 ER - TY - JOUR AU - Grundvold, I. AU - Bodegard, J. AU - Nilsson, P. M. AU - Svennblad, B. AU - Johansson, G. AU - Östgren, C. J. PY - 2015 DA - 2015// TI - Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study JO - Cardiovasc Diabetol VL - 14 UR - https://doi.org/10.1186/s12933-014-0170-3 DO - 10.1186/s12933-014-0170-3 ID - Grundvold2015 ER - TY - JOUR AU - Yamamoto, T. AU - Shimano, M. AU - Inden, Y. AU - Takefuji, M. AU - Yanagisawa, S. AU - Yoshida, N. PY - 2015 DA - 2015// TI - Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits JO - Heart Rhythm VL - 12 UR - https://doi.org/10.1016/j.hrthm.2015.03.010 DO - 10.1016/j.hrthm.2015.03.010 ID - Yamamoto2015 ER - TY - STD TI - Persson F, Nyström T, Jørgensen ME, Carstensen B, Gulseth HL, Thuresson M, et al. Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: a multinational observational study. Diabetes Obes Metab; 2017. (Epub ahead of print). ID - ref14 ER - TY - JOUR AU - Chen, H. Y. AU - Yang, F. Y. AU - Jong, G. P. PY - 2017 DA - 2017// TI - Liou YS Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients JO - Eur J Clin Invest VL - 47 UR - https://doi.org/10.1111/eci.12754 DO - 10.1111/eci.12754 ID - Chen2017 ER - TY - JOUR AU - Nakamura, T. AU - Iwanaga, Y. AU - Miyaji, Y. AU - Nohara, R. AU - Ishimura, T. AU - Miyazaki, S. PY - 2016 DA - 2016// TI - Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0371-z DO - 10.1186/s12933-016-0371-z ID - Nakamura2016 ER - TY - STD TI - National Health Insurance Administration, Ministry of Health and Welfare, Taiwan. The National Health Insurance Statistics; 2014. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&WD_ID=296&webdata_id=4835. UR - http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&WD_ID=296&webdata_id=4835 ID - ref17 ER - TY - JOUR AU - Wu, L. S. AU - Chang, S. H. AU - Chang, G. J. AU - Liu, J. R. AU - Chan, Y. H. AU - Lee, H. F. AU - Wen, M. S. AU - Chen, W. J. AU - Yeh, Y. H. AU - Kuo, C. T. AU - See, L. C. PY - 2016 DA - 2016// TI - A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0365-x DO - 10.1186/s12933-016-0365-x ID - Wu2016 ER - TY - JOUR AU - Austin, P. C. PY - 2014 DA - 2014// TI - The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments JO - Stat Med VL - 33 UR - https://doi.org/10.1002/sim.5984 DO - 10.1002/sim.5984 ID - Austin2014 ER - TY - JOUR AU - Chang, S. H. AU - Wu, L. S. AU - Chiou, M. J. AU - Liu, J. R. AU - Yu, K. H. AU - Kuo, C. F. AU - Wen, M. S. AU - Chen, W. J. AU - Yeh, Y. H. AU - See, L. C. PY - 2014 DA - 2014// TI - Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies JO - Cardiovasc Diabetol VL - 13 UR - https://doi.org/10.1186/s12933-014-0123-x DO - 10.1186/s12933-014-0123-x ID - Chang2014 ER - TY - JOUR AU - Lee, K. T. AU - Yeh, Y. H. AU - Chang, S. H. AU - See, L. C. AU - Lee, C. H. AU - Wu, L. S. AU - Liu, J. R. AU - Kuo, C. T. AU - Wen, M. S. PY - 2017 DA - 2017// TI - Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: a propensity score-matched nationwide study JO - Medicine (Baltimore) VL - 96 UR - https://doi.org/10.1097/MD.0000000000007507 DO - 10.1097/MD.0000000000007507 ID - Lee2017 ER - TY - JOUR AU - Benjamin, E. J. AU - Levy, D. AU - Vaziri, S. M. AU - D’Agostino, R. B. AU - Belanger, A. J. AU - Wolf, P. A. PY - 1994 DA - 1994// TI - Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JO - JAMA VL - 271 UR - https://doi.org/10.1001/jama.1994.03510350050036 DO - 10.1001/jama.1994.03510350050036 ID - Benjamin1994 ER - TY - JOUR AU - Ferrari, R. AU - Bertini, M. AU - Blomstrom-Lundqvist, C. AU - Dobrev, D. AU - Kirchhof, P. AU - Pappone, C. AU - Ravens, U. AU - Tamargo, J. AU - Tavazzi, L. AU - Vicedomini, G. G. PY - 2016 DA - 2016// TI - An update on atrial fibrillation in 2014: from pathophysiology to treatment JO - Int J Cardiol VL - 203 UR - https://doi.org/10.1016/j.ijcard.2015.10.089 DO - 10.1016/j.ijcard.2015.10.089 ID - Ferrari2016 ER - TY - JOUR AU - Aviles, R. J. AU - Martin, D. O. AU - Apperson-Hansen, C. AU - Houghtaling, P. L. AU - Rautaharju, P. AU - Kronmal, R. A. PY - 2003 DA - 2003// TI - Inflammation as a risk factor for atrial fibrillation JO - Circulation VL - 108 UR - https://doi.org/10.1161/01.CIR.0000103131.70301.4F DO - 10.1161/01.CIR.0000103131.70301.4F ID - Aviles2003 ER - TY - JOUR AU - Tadic, M. AU - Cuspidi, C. PY - 2015 DA - 2015// TI - Type 2 diabetes mellitus and atrial fibrillation: from mechanisms to clinical practice JO - Arch Cardiovasc Dis VL - 108 UR - https://doi.org/10.1016/j.acvd.2015.01.009 DO - 10.1016/j.acvd.2015.01.009 ID - Tadic2015 ER - TY - JOUR AU - Wang, M. T. AU - Lin, S. C. AU - Tang, P. L. AU - Hung, W. T. AU - Cheng, C. C. AU - Yang, J. S. PY - 2017 DA - 2017// TI - The impact of DPP4i inhibitors on long-term survival among diabetic patients after first acute myocardial infarction JO - Cardiovasc Diabetol VL - 16 UR - https://doi.org/10.1186/s12933-017-0572-0 DO - 10.1186/s12933-017-0572-0 ID - Wang2017 ER - TY - JOUR AU - Shah, Z. AU - Pineda, C. AU - Kampfrath, T. AU - Maiseyeu, A. AU - Ying, Z. AU - Racoma, I. PY - 2011 DA - 2011// TI - Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways JO - Vasc Pharmacol VL - 55 UR - https://doi.org/10.1016/j.vph.2011.03.001 DO - 10.1016/j.vph.2011.03.001 ID - Shah2011 ER - TY - JOUR AU - Ihara, M. AU - Asanuma, H. AU - Yamazaki, S. AU - Kato, H. AU - Asano, Y. AU - Shinozaki, Y. PY - 2015 DA - 2015// TI - An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury JO - Am J Physiol Heart Circ Physiol VL - 308 UR - https://doi.org/10.1152/ajpheart.00835.2014 DO - 10.1152/ajpheart.00835.2014 ID - Ihara2015 ER - TY - JOUR AU - Chang, C. J. AU - Yang, T. F. AU - Lee, T. I. AU - Chen, Y. C. AU - Kao, Y. H. AU - Chen, S. A. PY - 2014 DA - 2014// TI - Sitagliptin modulates the electrical and mechanical characteristics of pulmonary vein and atrium JO - Acta Cardiol Sin VL - 30 ID - Chang2014 ER - TY - JOUR AU - Zhang, X. AU - Zhang, Z. AU - Zhao, Y. AU - Jiang, N. AU - Qiu, J. AU - Yang, Y. PY - 2017 DA - 2017// TI - Alogliptin, a dipeptidyl peptidase-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits JO - J Am Heart Assoc VL - 6 UR - https://doi.org/10.1161/JAHA.117.005945 DO - 10.1161/JAHA.117.005945 ID - Zhang2017 ER - TY - JOUR AU - Hayami, N. AU - Sekiguchi, A. AU - Iwasaki, Y. K. AU - Murakawa, Y. AU - Yamashita, T. PY - 2016 DA - 2016// TI - No additional effect of DPP-4 inhibitor on preventing atrial fibrosis in streptozotocin-induced diabetic rat as compared with sulfonylurea JO - Int Heart J VL - 57 UR - https://doi.org/10.1536/ihj.15-266 DO - 10.1536/ihj.15-266 ID - Hayami2016 ER - TY - JOUR AU - Palmer, S. C. AU - Mavridis, D. AU - Nicolucci, A. AU - Johnson, D. W. AU - Tonelli, M. AU - Craig, J. C. PY - 2016 DA - 2016// TI - Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis JO - JAMA VL - 316 UR - https://doi.org/10.1001/jama.2016.9400 DO - 10.1001/jama.2016.9400 ID - Palmer2016 ER - TY - JOUR AU - Bennett, W. L. AU - Maruthur, N. M. AU - Singh, S. AU - Segal, J. B. AU - Wilson, L. M. PY - 2011 DA - 2011// TI - Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations JO - Ann Intern Med VL - 154 UR - https://doi.org/10.7326/0003-4819-154-9-201105030-00336 DO - 10.7326/0003-4819-154-9-201105030-00336 ID - Bennett2011 ER - TY - JOUR AU - Sarwar, N. AU - Gao, P. AU - Seshasai, S. R. AU - Gobin, R. AU - Kaptoge, S. AU - Angelantonio, E. PY - 2010 DA - 2010// TI - Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(10)60484-9 DO - 10.1016/S0140-6736(10)60484-9 ID - Sarwar2010 ER - TY - JOUR AU - Lamanna, C. AU - Monami, M. AU - Marchionni, N. AU - Mannucci, E. PY - 2011 DA - 2011// TI - Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials JO - Diabetes Obes Metab VL - 13 UR - https://doi.org/10.1111/j.1463-1326.2010.01349.x DO - 10.1111/j.1463-1326.2010.01349.x ID - Lamanna2011 ER - TY - JOUR AU - Zinman, B. AU - Wanner, C. AU - Lachin, J. M. AU - Fitchett, D. AU - Bluhmki, E. AU - Hantel, S. PY - 2015 DA - 2015// TI - Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504720 DO - 10.1056/NEJMoa1504720 ID - Zinman2015 ER - TY - JOUR AU - Monami, M. AU - Nreu, B. AU - Scatena, A. AU - Giannini, S. AU - Andreozzi, F. AU - Sesti, G. PY - 2017 DA - 2017// TI - Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials JO - J Endocrinol Invest VL - 40 UR - https://doi.org/10.1007/s40618-017-0698-7 DO - 10.1007/s40618-017-0698-7 ID - Monami2017 ER - TY - JOUR AU - Scirica, B. M. AU - Bhatt, D. L. AU - Braunwald, E. AU - Steg, P. G. AU - Davidson, J. AU - Hirshberg, B. PY - 2013 DA - 2013// TI - Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1307684 DO - 10.1056/NEJMoa1307684 ID - Scirica2013 ER - TY - JOUR AU - Yang, T. Y. AU - Liaw, Y. P. AU - Huang, J. Y. AU - Chang, H. R. AU - Chang, K. W. AU - Ueng, K. C. PY - 2016 DA - 2016// TI - Association of Sitagliptin with cardiovascular outcome in diabetic patients: a nationwide cohort study JO - Acta Diabetol VL - 53 UR - https://doi.org/10.1007/s00592-015-0817-x DO - 10.1007/s00592-015-0817-x ID - Yang2016 ER - TY - JOUR AU - Zannad, F. AU - Cannon, C. P. AU - Cushman, W. C. AU - Bakris, G. L. AU - Menon, V. AU - Perez, A. T. PY - 2015 DA - 2015// TI - Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)62225-X DO - 10.1016/S0140-6736(14)62225-X ID - Zannad2015 ER - TY - JOUR AU - Tomiyama, H. AU - Miwa, T. AU - Kan, K. AU - Matsuhisa, M. AU - Kamiya, H. AU - Nanasato, M. PY - 2016 DA - 2016// TI - Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0472-8 DO - 10.1186/s12933-016-0472-8 ID - Tomiyama2016 ER - TY - JOUR AU - White, W. B. AU - Cannon, C. P. AU - Heller, S. R. AU - Nissen, S. E. AU - Bergenstal, R. M. AU - Bakris, G. L. PY - 2013 DA - 2013// TI - Alogliptin after acute coronary syndrome in patients with type 2 diabetes JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1305889 DO - 10.1056/NEJMoa1305889 ID - White2013 ER - TY - JOUR AU - Green, J. B. AU - Bethel, M. A. AU - Armstrong, P. W. AU - Buse, J. B. AU - Engel, S. S. AU - Garg, J. PY - 2015 DA - 2015// TI - Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1501352 DO - 10.1056/NEJMoa1501352 ID - Green2015 ER - TY - JOUR AU - Ou, H. T. AU - Chang, K. C. AU - Li, C. Y. AU - Wu, J. S. PY - 2016 DA - 2016// TI - Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0350-4 DO - 10.1186/s12933-016-0350-4 ID - Ou2016 ER -